Authors
Latest:
College Students and Misuse of SubstancesThe prevalence of annual alcohol consumption is highest in full-time college students 1 to 4 years after high school.
Latest:
Methotrexate, Leflunomide Linked to Higher Risk of Adverse Pregnancy Outcomes in Patients With RADue to the increased possibility of adverse pregnancy outcomes associated with methotrexate and leflunomid, it is crucial that patients with rheumatoid arthritis (RA) engage in thorough consultations with their physicians regarding pregnancy planning.
Latest:
Insomnia and Bipolar Disorder: New DirectionsThe average patient with bipolar disorder struggles with sleep disorders. Here's how you can help.
Latest:
Improve Patient Care and Chronic Disease ManagementHealthcare professionals need to make patients the primary decision-makers in their own care and actively support their efforts to achieve their care goals.
Latest:
The Good, The Bad, and the Missed Opportunity of Mark Cuban Cost Plus Drug CompanyThe billionaire’s first venture into pharmacy launched earlier this year.
Latest:
Why Artificial Intelligence is Critical to the Success of Value-Based CareEmploying AI-driven technology ensures accurate and timely compliance with industry regulations, mitigates audits and fines, and helps forecast accurate reimbursements.
Latest:
Examining Barriers to Care in Diabetic Retinopathy ScreeningPrior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.
Latest:
Mirvetuximab Soravtansine for FRα+ Platinum-Resistant Ovarian Cancer Gets Full FDA ApprovalMirvetuximab soravtansine-gynx (Elahere) was first granted FDA accelerated approval in November 2022.
Latest:
Why Patient Education Is More Important Than EverHow pharmacists can address knowledge gaps and health literacy challenges to help people with chronic conditions stay adherent to drug therapies
Latest:
Mind-Body Resilience for Women: A Focus on DepressionDeveloping innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Latest:
Fish, Omega-3 Fatty Acid Intake Below Recommended Levels Among Pregnant WomenN-3 polyunsaturated fatty acids (PUFAs) are essential nutrients, especially during pregnancy as they support neurodevelopment in offspring and improve pregnancy outcomes.
Latest:
Bempedoic Acid for HypercholesterolemiaAn expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.
Latest:
Hospital Pharmacies and Budget Management: How Technology Can HelpThe hospital pharmacy must play its part by leveraging technology to control the costs of doing business and supporting the enterprise in addition to focusing on patient care.
Latest:
New Advances in Breast Cancer TherapyBreast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.
Latest:
Preventing Severe Respiratory Infections in ChildrenA refresher on best interventions for common respiratory disorders in children.
Latest:
New Report Scrutinizes PBM Spread Pricing PracticeFindings from the study conducted by 3 Axis Advisors confirm that PBM practices have an impact on pharmacies.
Latest:
COVID-19 National Emergencies to End in MayThe public health emergency, which was set to end April 11, and the national emergency, which was set to end March 1, will be ended on May 11 by the Biden administration.
Latest:
Mind-Body Resilience for Women: A Focus on DepressionDeveloping innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Latest:
Inflation Reduction Act and Its Impact on Pharmaceutical Pricing and Investment DecisionsThe reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Latest:
How Vitamin D Can Help Migraines In Young PatientsVitamin D supplementation may be an effective and safe adjunctive prophylactic therapy to topiramate for children who experience migraine attacks, showed a study conducted in Saudi Arabia.
Latest:
Holistic Treatment Techniques for Managing Atopic DermatitisPatients are finding relief in alternative therapies for this chronic skin disease.
Latest:
Racial, Ethnic Inequities Persist in Diabetes CareSignificant differences in the use of insulin pump and/or CGM technology were noted based on demographic and socioeconomic factors
Latest:
Bosutinib Approved by FDA for Pediatric Chronic Myelogenous LeukemiaPositive findings from the phase 1/2 BCHILD study supported the approval decision.
Latest:
FDA Requests Black Box Warning for Approved CAR-T Therapies Over Secondary Cancer ConcernAs per US law Section 505(o)(4), the manufacturers are required to make the requested changes, respond with a modified version of the requested changes for review, or respond with a rebuttal within 30 days of the FDA's ask.
Latest:
COVID-19 Vaccination Rates Significantly Lower in Patients With Sickle Cell DiseasePatients with SCD are more vulnerable to hospitalization due, in part, to SCD’s impact on the spleen, which filters infections in the blood and is a crucial organ for the immune system.
Latest:
Advanced Health Care Technology Solutions Can Help Both Providers and PayersIntegrating evidence-based treatment protocols through a streamlined approach enables the delivery of higher quality, comprehensive care.
Latest:
Veterinary Prescriptions Made EasyHow can e-prescribing improve the workflow between pharmacists and their veterinarian colleagues?
Latest:
How to Balance Your Time in the PharmacyA shift in mindset and priorities can help you improve staff performance, acquire new patients, and leverage technology for more efficient operations.
Latest:
IQVIA Predicts Biosimilar, Generic Competition Will Cost Originators $192 Billion by 2028According to the most recent Global Use of Medicine report issued by the IQVIA Institute for Human Data Science, losses for originator products are projected to rise by over $80 billion over the next 5 years due to market introductions of new biosimilar and generic drugs.
